Premium
Treatment of chronic urticaria with a beta 2 ‐adrenergic stimulant
Author(s) -
KENNES B.,
MAUBEUGE J.,
DELESPESSE G.
Publication year - 1977
Publication title -
clinical and experimental allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 154
eISSN - 1365-2222
pISSN - 0954-7894
DOI - 10.1111/j.1365-2222.1977.tb01422.x
Subject(s) - terbutaline , stimulant , medicine , adrenergic , asthma , cholinergic , beta (programming language) , pharmacology , anesthesia , receptor , computer science , programming language
Summary Twenty‐four patients with chronic urticaria resistant to conventional therapy were treated orally with terbutaline, a specific β 2 stimulant. This therapy was much more effective than antihistamines. At the dose of 1.25 mg three times a day, there were few side effects. The efficacy was independent of the IgE levels; it seemed greater in idiopathic cases than in cholinergic or pressure induced urticaria.